| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3083979 | F | Antifungal activity against Candida albicans assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Candida albicans | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 2. | ALA3083980 | F | Antifungal activity against Aspergillus niger assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Aspergillus niger | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 3. | ALA3083981 | F | Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhi assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Salmonella enterica subsp. enterica serovar Typhi | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 4. | ALA3083982 | F | Antibacterial activity against Proteus vulgaris assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Proteus vulgaris | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 5. | ALA3083983 | F | Antibacterial activity against Escherichia coli assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Escherichia coli | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 6. | ALA3083984 | F | Antibacterial activity against Bacillus subtilis assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Bacillus subtilis | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 7. | ALA3083985 | F | Antibacterial activity against Klebsiella pneumoniae assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Klebsiella pneumoniae | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 8. | ALA3083986 | F | Antibacterial activity against Staphylococcus aureus assessed as growth inhibition at 50 ug/ml by cup-plate method (Rvb = 8 to 10 mm) | Staphylococcus aureus | 11 | ALA3045116 | organism-based format | Scientific Literature | |
| 9. | ALA3072240 | F | Antiviral activity against Influenza B virus infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Influenza B virus | 14 | ALA3045116 | organism-based format | Scientific Literature | |
| 10. | ALA3072241 | F | Antiviral activity against Influenza A virus H3N2 infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Influenza A virus H3N2 | 14 | ALA3045116 | organism-based format | Scientific Literature | |
| 11. | ALA3075258 | F | Antiviral activity against Unidentified Influenza A virus (H1N1) infected MDCK cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Influenza A virus | 14 | ALA3045116 | organism-based format | Scientific Literature | |
| 12. | ALA3075259 | A | Cytotoxicity against MDCK cells assessed as change in cellular morphology | Canis lupus familiaris | 14 | ALA3045116 | cell-based format | Scientific Literature | |
| 13. | ALA3075260 | F | Antiviral activity against Punta Toro virus infected in African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Punta Toro virus | 12 | ALA3045116 | organism-based format | Scientific Literature | |
| 14. | ALA3075261 | F | Antiviral activity against Human coxsackievirus B4 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Coxsackievirus B4 | 12 | ALA3045116 | organism-based format | Scientific Literature | |
| 15. | ALA3075262 | F | Antiviral activity against Sendai virus infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Respirovirus muris | 12 | ALA3045116 | organism-based format | Scientific Literature | |
| 16. | ALA3075263 | F | Antiviral activity against Mammalian orthoreovirus 1 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Mammalian orthoreovirus 1 | 12 | ALA3045116 | organism-based format | Scientific Literature | |
| 17. | ALA3075264 | F | Antiviral activity against Human parainfluenza virus 3 infected African green monkey Vero cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Human respirovirus 3 | 12 | ALA3045116 | organism-based format | Scientific Literature | |
| 18. | ALA3075265 | A | Cytotoxicity against Chlorocebus aethiops (African green monkey) Vero cells assessed as change in cellular morphology | Chlorocebus sabaeus | 12 | ALA3045116 | cell-based format | Scientific Literature | |
| 19. | ALA3075266 | F | Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Respiratory syncytial virus | 12 | ALA3045116 | organism-based format | Scientific Literature | |
| 20. | ALA3075712 | F | Antiviral activity against Vesicular stomatitis virus infected human HeLa cells assessed as reduction of virus-induced cytopathic effect after 3 days by colorimetric formazan-based MTS assay | Vesicular stomatitis virus | 12 | ALA3045116 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!